FGF11
Fibroblast growth factor 11
Also known as: FGF11_HUMAN, FHF3, FLJ16061, MGC102953, MGC45269
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92914
- Gene
- FGF11
- Ensembl
- ENSG00000161958
- Chromosome
- 17
- Canonical length
- 225 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centrosome
OverviewNCBI Gene
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. The function of this gene has not yet been determined. The expression pattern of the mouse homolog implies a role in nervous system development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
225 residues, UniProt reviewed canonical sequence.
>Q92914|FGF11
1 MAALASSLIR QKREVREPGG SRPVSAQRRV CPRGTKSLCQ KQLLILLSKV RLCGGRPARP
61 DRGPEPQLKG IVTKLFCRQG FYLQANPDGS IQGTPEDTSS FTHFNLIPVG LRVVTIQSAK
121 LGHYMAMNAE GLLYSSPHFT AECRFKECVF ENYYVLYASA LYRQRRSGRA WYLGLDKEGQ
181 VMKGNRVKKT KAAAHFLPKL LEVAMYQEPS LHSVPEASPS SPPAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FGF11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 31 nTPM
- esophagus: 20 nTPM
- skin: 18 nTPM
- vagina: 16 nTPM
- heart muscle: 16 nTPM
- retina: 14 nTPM
Single-cell type
- astrocytes: 17 nCPM
- bergmann glia: 8.5 nCPM
- oligodendrocyte progenitor cells: 7.7 nCPM
- loop of henle epithelial cells: 4.5 nCPM
- brain inhibitory neurons: 3.5 nCPM
- papillary tip epithelial cells: 1.8 nCPM
Immune cell
- eosinophil: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 20 nTPM
- thalamus: 20 nTPM
- medulla oblongata: 15 nTPM
- midbrain: 13 nTPM
- basal ganglia: 13 nTPM
- pons: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FGF11 as an antibody target. Whether an autoantibody or antibody against FGF11 could matter depends on whether native FGF11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FGF11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FGF11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...